Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Enterprise Value: 7.383M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 7.383M |
| November 14, 2024 | 7.737M |
| November 13, 2024 | 8.086M |
| November 12, 2024 | 8.673M |
| November 11, 2024 | 8.754M |
| November 08, 2024 | 8.659M |
| November 07, 2024 | 8.324M |
| November 06, 2024 | 5.516M |
| November 05, 2024 | 5.701M |
| November 04, 2024 | 6.119M |
| November 01, 2024 | 6.538M |
| October 31, 2024 | 7.024M |
| October 30, 2024 | 8.097M |
| October 29, 2024 | 7.543M |
| October 28, 2024 | 7.852M |
| October 25, 2024 | 7.396M |
| October 24, 2024 | 7.415M |
| October 23, 2024 | 7.886M |
| October 22, 2024 | 7.103M |
| October 21, 2024 | 7.532M |
| October 18, 2024 | 4.665M |
| October 17, 2024 | 4.654M |
| October 16, 2024 | 4.756M |
| October 15, 2024 | 4.699M |
| October 14, 2024 | 4.582M |
| Date | Value |
|---|---|
| October 11, 2024 | 4.801M |
| October 10, 2024 | 4.763M |
| October 09, 2024 | 4.612M |
| October 08, 2024 | 4.469M |
| October 07, 2024 | 5.042M |
| October 04, 2024 | 4.703M |
| October 03, 2024 | 4.857M |
| October 02, 2024 | 4.774M |
| October 01, 2024 | 4.993M |
| September 30, 2024 | 5.340M |
| September 27, 2024 | 4.296M |
| September 26, 2024 | 4.627M |
| September 25, 2024 | 4.005M |
| September 24, 2024 | 3.763M |
| September 23, 2024 | 3.674M |
| September 20, 2024 | 3.998M |
| September 19, 2024 | 4.035M |
| September 18, 2024 | 5.185M |
| September 17, 2024 | 5.710M |
| September 16, 2024 | 5.453M |
| September 13, 2024 | 5.785M |
| September 12, 2024 | 5.077M |
| September 11, 2024 | 5.614M |
| September 10, 2024 | 6.150M |
| September 09, 2024 | 6.678M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.66M
Minimum
Mar 14 2022
272.51M
Maximum
Jan 22 2021
51.61M
Average
16.52M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | -6.042M |
| AIM ImmunoTech Inc | 6.697M |
| Perspective Therapeutics Inc | 240.17M |
| Protalix BioTherapeutics Inc | 78.35M |
| Armata Pharmaceuticals Inc | 172.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.41M |
| Total Expenses (Quarterly) | 1.457M |
| EPS Diluted (Quarterly) | -0.04 |
| Earnings Yield | -683.3% |